"Huntingtin Holiday": Progress toward an Antisense Therapy for Huntington's Disease

被引：41
作者：
Lu, Xiao-Hong [1 ,2 ,3 ]
Yang, X. William [1 ,2 ,3 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Inst Brain Res, Los Angeles, CA 90095 USA
来源：
NEURON | 2012年 / 74卷 / 06期
关键词：
MUTANT HUNTINGTIN; MOUSE MODEL; MICE; OLIGONUCLEOTIDES; NEUROPATHOLOGY; PATHOGENESIS; BRAIN; MOTOR;
D O I：
10.1016/j.neuron.2012.06.001
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
Lowering mutant Huntingtin is a consensus therapeutic strategy for Huntington's disease. In this issue of Neuron, Kordasiewicz et al. (2012) show the benefit of transient antisense oligonucleotide (ASO) therapy to degrade Huntingtin mRNA and elicit sustained therapeutic benefit in HD mice.
引用
收藏
页码：964 / 966
页数：3
相关论文
共 50 条
  • [21] Dose-Dependent Lowering of Mutant Huntingtin Using Antisense Oligonucleotides in Huntington Disease Patients
    van Roon-Mom, Willeke M. C.
    Roos, Raymund A. C.
    de Bot, Susanne T.
    NUCLEIC ACID THERAPEUTICS, 2018, 28 (02) : 59 - 62
  • [22] Disease-related Huntingtin seeding activities in cerebrospinal fluids of Huntington's disease patients
    Lee, C. Y. Daniel
    Wang, Nan
    Shen, Koning
    Stricos, Matthew
    Langfelder, Peter
    Cheon, Kristina H.
    Cortes, Etty P.
    Vinters, Harry V.
    Vonsattel, Jean Paul
    Wexler, Nancy S.
    Damoiseaux, Robert
    Frydman, Judith
    Yang, X. William
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [23] The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington's disease
    Tung, Chih-Wei
    Huang, Pin-Yu
    Chan, Siew Chin
    Cheng, Pei-Hsun
    Yang, Shang-Hsun
    JOURNAL OF BIOMEDICAL SCIENCE, 2021, 28 (01)
  • [24] PIAS1 Regulates Mutant Huntingtin Accumulation and Huntington's Disease-Associated Phenotypes In Vivo
    Ochaba, Joseph
    Monteys, Alex Mas
    O'Rourke, Jacqueline G.
    Reidling, Jack C.
    Steffan, Joan S.
    Davidson, Beverly L.
    Thompson, Leslie M.
    NEURON, 2016, 90 (03) : 507 - 520
  • [25] Autophagy in Huntington disease and huntingtin in autophagy
    Martin, Dale D. O.
    Ladha, Safia
    Ehrnhoefer, Dagmar E.
    Hayden, Michael R.
    TRENDS IN NEUROSCIENCES, 2015, 38 (01) : 26 - 35
  • [26] Antisense Oligonucleotide Therapy: From Design to the Huntington Disease Clinic
    Rook, Morgan E.
    Southwell, Amber L.
    BIODRUGS, 2022, 36 (02) : 105 - 119
  • [27] Postnatal and adult consequences of loss of huntingtin during development: Implications for Huntington's disease
    Arteaga-Bracho, Eduardo E.
    Gulinello, Maria
    Winchester, Michael L.
    Pichamoorthy, Nandini
    Petronglo, Jenna R.
    Zambrano, Alicia D.
    Inocencio, Julio
    De Jesus, Chirstopher D.
    Louie, Joseph O.
    Gokhan, Solen
    Mehler, Mark F.
    Molero, Aldrin E.
    NEUROBIOLOGY OF DISEASE, 2016, 96 : 144 - 155
  • [28] Dynamics of huntingtin protein interactions in the striatum identifies candidate modifiers of Huntington disease
    Greco, Todd M.
    Secker, Christopher
    Ramos, Eduardo Silva
    Federspiel, Joel D.
    Liu, Jeh-Ping
    Perez, Alma M.
    Al-Ramahi, Ismael
    Cantle, Jeffrey P.
    Carroll, Jeffrey B.
    Botas, Juan
    Zeitlin, Scott O.
    Wanker, Erich E.
    Cristea, Ileana M.
    CELL SYSTEMS, 2022, 13 (04) : 304 - +
  • [29] Reviewing Biochemical Implications of Normal and Mutated Huntingtin in Huntington's Disease
    Tellone, Ester
    Galtieri, Antonio
    Ficarra, Silvana
    CURRENT MEDICINAL CHEMISTRY, 2020, 27 (31) : 5137 - 5158
  • [30] Salivary levels of total huntingtin are elevated in Huntington's disease patients
    Corey-Bloom, Jody
    Haque, Ameera S.
    Park, Sungmee
    Nathan, Ajay S.
    Baker, Robert W.
    Thomas, Elizabeth A.
    SCIENTIFIC REPORTS, 2018, 8
12345